Wang led the 5G Core Technologies and Engineering Application Project. In 2023, the project received the first prize of State Scientific and Technological Progress Award. The project helps ensure ...

Parents who discussed HPV vaccines with a chatbot were three times more likely to vaccinate their children. So could your ...

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

Despite some optimism in the market after President Donald Trump’s indication of possible talks with China, Wall Street ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable solutions for medical applications.

1 School of Management, Beijing University of Chinese Medicine, Beijing ... conducted extensive research on HPV infection in women and the prevention of cervical cancer through HPV vaccination, but ...

A definitive documentary with a soaring ambition: to help accelerate the elimination of cervical cancer for every woman and girl in the USA and beyond. Conquering Cervical Cancer is available to ...

Navigating the landscape of cervical cancer in India: Epidemiology, prevention, current status, and emerging solutions Go to source), contributing to nearly one-quarter of global deaths from the ...

New Delhi: Indigenously developed (Human papillomavirus) HPV test kits for cervical cancer screening were launched here on Wednesday. The test kits have been developed under the Department of ...

The study titled 'Validation of Indigenous Human Papillomavirus Tests for Cervical Cancer Screening in India (i-HPV)' validated indigenously developed, rapid, point-of-care, RTPCR-based HPV ...

Jitendra Singh, Union Minister of State for Science and Technology, officially launched indigenously developed HPV test kits for cervical cancer screening at a high-profile event in Delhi on Thursday.

The kits, which employ a chip-based RT-PCR testing method, facilitate rapid and decentralised detection of eight high-risk HPV genotypes - accounting for over 96% of cervical cancer cases worldwide.